BRIEF-Edwards Lifesciences Corp Q4 EPS $0.73

* Q4 global transcatheter heart valve therapy sales up 29 percent to $432 million [Source]

Publication Date: Wednesday, 1 February 2017 at 23:26:38

Origin: reuters.com

Category: rbssHealthcareNews

Topics: million, 29 percent, sales, therapy, valve, heart, transcatheter, global, Lifesciences, BRIEF-Edwards

Source: http://feeds.reuters.com/~r/reuters/UShealthcareNews/~3/yVkPyOtNMOY/idUSB8N1AL030

Related Articles

Drugmakers look for reciprocal UK-EU regulation after Brexit

[ reuters.com ] rbssHealthcareNews, Thursday, 2 February 2017 at 18:26:46

UPDATE 1-Opioid addiction implant maker Braeburn Pharma pulls IPO

[ reuters.com ] rbssHealthcareNews, Thursday, 2 February 2017 at 18:10:46

BRIEF-Nestle Health Science plans to expand manufacturing facility in Eau Claire, Wi

[ reuters.com ] rbssHealthcareNews, Thursday, 2 February 2017 at 17:45:15

BRIEF-Medivir says EGM backs redemption programme

[ reuters.com ] rbssHealthcareNews, Thursday, 2 February 2017 at 16:54:21

BRIEF-Cymabay announces pricing of public offering of common stock

[ reuters.com ] rbssHealthcareNews, Thursday, 2 February 2017 at 16:37:22